Discover the latest insights in liver disease management in the FINAL issue of Clinical Liver Disease! @CLD_Learning https://t.co/pAfiWXtNWQ #LiverTwitter

Check out History of Hepatology collection on landmark events of our field! Full collection- https://t.co/SWFwY2vGyN Liver biopsy - https://t.co/XLtwYCeNYr Liver transplant - https://t.co/MbKCfXPMNR Liver surgery - https://t.co/5lEoWlrtFD

*New CLD series* @BrettEFortune & Shari Royal expertly curated series on improving Quality of Care in Cirrhosis. An increasingly important topic. Full series: https://t.co/BXT9THJkpN Sample content: https://t.co/jkABUvEJQt https://t.co/C5Nvj29WCj

The evidence for fecal microbiota transplantation efficacy in liver disease continues to emerge Read a comprehensive overview of the current state of play here: https://t.co/vmmiJQfS9O

Addictive disorders are increasingly impacting liver disease outcomes J Mellinger @lykhaque edit this crucial CLD series on addiction and liver disease. A must read! Full series: https://t.co/mxIPw3bI9m Sample content: https://t.co/A5GUgNiJjA https://t.co/A5GUgNiJjA

Opportunities for harnessing digital technologies to improve outcomes in cirrhosis. A great overview by the field leaders @jlouissaint89 @TiffanyWuMD https://t.co/N6A3dhMhMQ

*NEW SERIES* edited by @serperm @yucaspice Functional status is critical in determining outcomes in cirrhosis. Nutrition: https://t.co/jx2n4uckpK Untangling sarcopenia, frailty, and fitness: https://t.co/4nn1Znjmby Series link (when all published) https://t.co/QSOdgFjjZu

Check out new articles added to our HCC series from debate on immunotherapy in LT, expansion of surgical candidates, biomarkers and updates on LT policy. https://t.co/90ex2SOCTq https://t.co/OgflVG2cbC https://t.co/J3BYtbY7PZ https://t.co/zTHTESHzxW https://t.co/pPo9sTsRsY

A succinct review on management of hepatitis B reactivation. Risks and decision for prophylaxis are based on serologic status of patients and type of immunosuppressive therapy. Helpful figure to guide decision making. https://t.co/XEXw5w7N44

The role of immunotherapy in the evolving landscape of HCC treatment in the context of liver transplant. Promising use needs to be balanced with allograft rejection Expert opinion suggest a minimal of 12-week washout, more data needed https://t.co/OXYIORXQy9

2 more from our Hep B elimination series https://t.co/BYv18srKDD -Elimination: https://t.co/xoBlzPYbE5 -Functional cure (Anna Lok): 3%–5% after 10 yrs of nucleos(t)ide analogs; 8%–14% after 3–5 years of 48-wks of peg interferon. Trials also discussed https://t.co/5rfxdX05OW

The most in-depth and interesting article on the evolution of the Cardio-Hepatology field, a truly unique relationship: https://t.co/IMvLpX9ylI See the entire series of History of Hepatology collection here: https://t.co/KgiGEPzGhx

Check out two recently published articles on the advances in Hepaititis B and Hepatitis D treatments! https://t.co/CaKWknSBPa https://t.co/mSAOxHgmPT

@agud__MD @AlexanderPodboy explore the ever expanding field of endo-bariatric therapies in treating MASLD Endo Balloon & Sleeve Gastroplasty nuances and efficacy expertly discussed https://t.co/iHztyvdPw3

@RobertFontanaMD & colleagues @MichiganLiver guide us through the challenging (& common) scenario of how to establish a diagnosis of DILI in patients on chemotherapy in a stepwise fashion A case of PKI-associated cholestatic granulomatous hepatitis: https://t.co/qVKmJ4Kw44

Two interesting articles on infantile cholestasis 1. Renal lesion associations: https://t.co/oi4AuusjAP 2. Biliary atresia case: https://t.co/GfqmY4fibh @anouti_ahmad @BAREInc_org

CLD series is curated by our Guest Editors to bring articles together to capture intent of the series. https://t.co/3mlq57eGVk Check out the new content added to the "Pregnancy and Liver Disease" series. https://t.co/rg9s7D5Gns https://t.co/8rPIbLSwdT https://t.co/BRxIwvWY4K

Metabolic Disorders play an important role in modifying hepatitis B outcomes From our upcoming "Current Challenges in the Management of Chronic Hepatitis B Infection" series collection: https://t.co/6333RzgmT5

Editor-in-Chief Dr. Joseph K. Lim's editorial @CLD_Learning Clinical Liver Disease: Legacy of innovation in hepatology education https://t.co/L9QkFZCXVP

Check out this review and interview with the author on inpatient management of fluid overload in patients with decompensated cirrhosis. https://t.co/Ao7LjstjTa